GC-1130A
- Generic Name
- GC-1130A
Phase 1 Study of GC1130A in Pediatric Patients With Sanfilippo Syndrome Type A (MPS IIIA)
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- GC Biopharma Corp
- Target Recruit Count
- 9
- Registration Number
- NCT06567769
- Locations
- 🇯🇵
National Center for Child Health and Development, Setagaya, Tokyo, Japan
🇺🇸UCSF Benioff Children's Hospital, Oakland, California, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath